![]() |
市場調査レポート
商品コード
1622358
小動物イメージング市場規模、シェア、成長分析、モダリティ別、用途別、試薬別、地域別 - 産業予測、2025~2032年Small Animal Imaging Market Size, Share, Growth Analysis, By Modality (Optical Imaging Systems, Nuclear Imaging), By Application (Monitoring Drug Treatment Response, Biodistribution Studies), By Reagent, By Region - Industry Forecast 2025-2032 |
||||||
|
小動物イメージング市場規模、シェア、成長分析、モダリティ別、用途別、試薬別、地域別 - 産業予測、2025~2032年 |
出版日: 2024年12月23日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
小動物イメージング市場規模は、2023年に93億9,000万米ドルと評価され、2024年の99億9,000万米ドルから2032年には164億4,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは6.42%で成長する見通しです。
世界の小動物イメージング市場は、創薬、疾患研究、生物学的プロセスの解明における重要な役割によって、著しい成長を遂げています。この分野は、分子や細胞のメカニズムに関する重要な洞察を提供し、標的療法や個別化治療戦略の開発を促進します。製薬業界とバイオテクノロジー業界は、新薬候補の安全性と有効性を評価する前臨床試験に依存しており、これらの技術に対する需要を大幅に押し上げています。高解像度画像モダリティや強化されたスキャン機能などの技術的進歩は、前臨床評価の精度と効率を向上させ、市場拡大をさらに後押ししています。さらに、マルチモーダルイメージング技術やハイブリッドシステムの統合により、小動物イメージングの能力は拡大し、研究や治療開発の進展に不可欠な、より豊富で正確なデータ取得が可能になりました。
Small Animal Imaging Market size was valued at USD 9.39 Billion in 2023 and is poised to grow from USD 9.99 Billion in 2024 to USD 16.44 Billion by 2032, growing at a CAGR of 6.42% during the forecast period (2025-2032).
The global small animal imaging market is witnessing remarkable growth, driven by its vital role in drug discovery, disease research, and biological process understanding. This sector provides crucial insights into molecular and cellular mechanisms, facilitating the development of targeted therapies and personalized treatment strategies. The pharmaceutical and biotechnology industries significantly boost demand for these technologies, relying on preclinical studies to assess new drug candidates' safety and efficacy. Technological advancements, such as high-resolution imaging modalities and enhanced scanning capabilities, have further propelled market expansion, improving the accuracy and efficiency of preclinical assessments. Additionally, the integration of multimodal imaging techniques and hybrid systems has broadened small animal imaging's capabilities, allowing for richer and more precise data acquisition, crucial for advancing research and therapeutic development.
Top-down and bottom-up approaches were used to estimate and validate the size of the Small Animal Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Small Animal Imaging Market Segmental Analysis
Global Small Animal Imaging Market is segmented by modality, application, reagent and region. Based on modality, the market is segmented into optical imaging systems, nuclear imaging and other imaging modalities. Based on application, the market is segmented into monitoring drug treatment response, biodistribution studies, cancer cell detection, biomarkers, longitudinal studies and epigenetics. Based on reagents, the market is segmented into optical imaging reagents and nuclear imaging reagents. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Small Animal Imaging Market
The Small Animal Imaging market is primarily driven by the increasing focus on preclinical research within the pharmaceutical, biotechnology, and life sciences sectors. As the need for detailed investigations into diseases intensifies, the demand for sophisticated small animal imaging systems is on the rise. These cutting-edge imaging technologies provide researchers with the capability to perform comprehensive studies on various diseases, track their progression, assess the efficacy of treatments, and evaluate the safety and toxicity of novel drugs or therapies. This heightened emphasis on preclinical research is significantly contributing to the growth of the small animal imaging market.
Restraints in the Small Animal Imaging Market
The Small Animal Imaging market faces several constraints, notably the restricted availability of imaging agents. The process of developing and validating imaging agents specifically designed for preclinical studies can be both lengthy and expensive, which hinders their broader acceptance and use. This scarcity of suitable imaging agents can significantly affect the overall deployment of small animal imaging technologies within research environments, leading to potential delays in scientific progress and diminishing the effectiveness of preclinical studies. Consequently, this limitation may restrict researchers' ability to achieve comprehensive results, ultimately impacting the growth and application of the Small Animal Imaging market.
Market Trends of the Small Animal Imaging Market
The global small animal imaging market is witnessing a significant trend towards the increased adoption of multimodal imaging techniques, which integrate various imaging modalities to enhance the understanding of biological processes and disease progression in small animals. This trend is propelled by the demand for more precise and detailed imaging data in preclinical research and drug development. By utilizing a combination of techniques like positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), and optical imaging, researchers gain complementary insights that improve the sensitivity and specificity of imaging studies, ultimately fostering advancements in therapeutic efficacy and research outcomes.